• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Larimar Therapeutics, Inc. - Common Stock (NQ:LRMR)

2.670 -0.030 (-1.11%)
Delayed Quote Updated: 4:00 PM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 868,879
Open 2.680
Bid (Size) 2.640 (100)
Ask (Size) 2.850 (500)
Prev. Close 2.700
Today's Range 2.620 - 2.740
52wk Range 2.610 - 6.420
Shares Outstanding 43,269,200
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead ↗
Today 10:35 EDT
Inventiva, Larimar Therapeutics, and Ascentage Pharma face key drug-development milestones, with analysts assigning Buy ratings and triple-digit upside price targets to all three biotech stocks. 
Via MarketBeat
News headline image
Century Therapeutics Appoints Joseph Truitt to Board of Directors
September 09, 2026
From Century Therapeutics, Inc.
Via GlobeNewswire

Performance

52-Week Range 58.4% below 52-week high
2.670
2.6152W Low 6.4252W High
1 Week 12.2% below 1-week high
2.611W Low 3.041W High

Larimar Therapeutics, Inc. - Common Stock (LRMR) traded between $2.61 and $6.42 over the past 52 weeks and last traded at $2.67, 58.4% below its 52-week high. Over the past week it ranged between $2.61 and $3.04.

Past 12 Months
-6.6%
-31.0%
-37.6%
-44.9%
-23.1%
-41.3%
1W -$0.19
1M -$1.20
3M -$1.61
6M -$2.18
YTD -$0.80
1Y -$1.88

LRMR was -41.3% over the past year, -44.9% over six months, -23.1% year to date, -6.6% in the last week.

12 Months vs Market
LRMR
-41.3%
DIA
+11.4%
SPY
+16.0%
QQQ
+23.0%
IWM
+13.8%

Over the past 12 months LRMR returned -41.3% versus DIA (Dow) +11.4%, SPY (S&P 500) +16.0%, QQQ (Nasdaq 100) +23.0% and IWM (Russell 2000) +13.8%.

Volume & Liquidity 0.69× 3-mo avg
Today 868,879 3-mo avg 1.3M
1W
898.1K
1M
1.4M
3M
1.3M
6M
1.7M
YTD
2.5M
1Y
2.3M

LRMR most recently traded 868,879 shares against a 3-month average daily volume of 1.3M.

More News

Read More
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Larimar Therapeutics, Inc. - LRMR
July 21, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR
July 14, 2026
From Pomerantz LLP
Via GlobeNewswire
There are notable gap-ups and gap-downs in today's session. ↗
July 09, 2026
Via Chartmill
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR
July 07, 2026
From Pomerantz LLP
Via GlobeNewswire
Get insights into the top gainers and losers of Monday's pre-market session. ↗
June 29, 2026
Via Chartmill
Unusual volume stocks are being observed in Thursday's session. ↗
February 26, 2026
Via Chartmill
News headline image
Stocks Under $5 to Watch Now: LRMR, RXRX, NDRA, BTQ, CDIO Watch Now!
February 26, 2026
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
News headline image
Nasdaq, S&P 500 Futures Tread Caution On Nvidia’s China Risk: Why NFLX, WBD, AAPL, CRM, AI, LRMR Are On Traders' Radar Today ↗
February 26, 2026
Via Stocktwits
Topics Artificial Intelligence ETFs Stocks
News headline image
Larimar Prices $100M Stock Sale After Record Rally Fueled By FDA Breakthrough Tag For Protein Replacement Therapy ↗
February 25, 2026
Via Stocktwits
Let's take a look at the stocks that are in motion in today's session. ↗
February 25, 2026
Via Chartmill
News headline image
Laminar Therapeutics Stock Is Popping Today: What's Going On? ↗
February 25, 2026
Via Benzinga
These stocks are the most active in today's session ↗
February 25, 2026
Via Chartmill
The trading volume of these stocks is deviating from the norm in today's session. ↗
February 25, 2026
Via Chartmill
Here are the top movers in Wednesday's session. ↗
February 25, 2026
Via Chartmill
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
February 24, 2026
Via Chartmill
Curious about the most active stocks on Tuesday? ↗
February 24, 2026
Via Chartmill
Tuesday's session: top gainers and losers ↗
February 24, 2026
Via Chartmill
News headline image
Larimar Therapeutics (LRMR) Surges On FDA Breakthrough Therapy Designation ↗
February 24, 2026
Via Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
February 24, 2026
Via Chartmill
News headline image
Why Did Larimar Therapeutics’ Stock Surge Over 30% Pre-Market Today? ↗
February 24, 2026
Via Stocktwits
Which stocks are moving before the opening bell on Tuesday? ↗
February 24, 2026
Via Chartmill
News headline image
What's going on in today's after hours session ↗
November 17, 2025
Via Chartmill
News headline image
Rosen Law Firm Encourages Larimar Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – LRMR
October 30, 2025
From The Rosen Law Firm, P.A.
Via Business Wire

Frequently Asked Questions

Is Larimar Therapeutics, Inc. - Common Stock publicly traded?
Yes, Larimar Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Larimar Therapeutics, Inc. - Common Stock trade on?
Larimar Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Larimar Therapeutics, Inc. - Common Stock?
The ticker symbol for Larimar Therapeutics, Inc. - Common Stock is LRMR on the Nasdaq Stock Market
What is the current price of Larimar Therapeutics, Inc. - Common Stock?
The current price of Larimar Therapeutics, Inc. - Common Stock is 2.670
When was Larimar Therapeutics, Inc. - Common Stock last traded?
The last trade of Larimar Therapeutics, Inc. - Common Stock was at 10/09/26 04:00 PM ET
What is the market capitalization of Larimar Therapeutics, Inc. - Common Stock?
The market capitalization of Larimar Therapeutics, Inc. - Common Stock is 115.53M
How many shares of Larimar Therapeutics, Inc. - Common Stock are outstanding?
Larimar Therapeutics, Inc. - Common Stock has 116M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap